
VITALITY Ecosystem Funds preclinics Italia in Biotech Consortium for Antibody Development
preclinics Italia, along with its partners Diatheva and Toscana Life Sciences, has secured funding for the innovative PISAMUNAB project, aimed at revolutionizing the landscape of